868 research outputs found
Photovaporisation prostatique au laser chez les patients à haut risque hémorragique
Introduction: Les patients sous traitement anticoagulant sont Ă risque élevĂ© de saignement lors de la rĂ©section transurĂ©trale de la prostate ou del'adĂ©nomectomie par taille vĂ©sicale et ils se voient souvent rĂ©cuser pour la chirurgie de l'hyperplasie bĂ©nigne de la prostate symptomatique. En Utilisant la photovaporisation de la prostate, les patients Ă haut risque peuvent subir en toute sĂ©curitĂ© la chirurgie. Nous avons Ă©valuĂ© l'innocuitĂ© et l'efficacitĂ© de la photovaporisation de la prostate (PVP) chez les patients sous anticoagulants en cours avec les dĂ©rivĂ©s de la coumarine, l'aspirineou le clopidogrel, se plaignant de symptĂŽmes d'hypertrophie bĂ©nigne de la prostate.MĂ©thodes: Entre janvier 2009 et mai 2010, 47 hommes sous anticoagulation systĂ©mique ont subi une photovaporisation de la prostate. Les donnĂ©es ont Ă©tĂ© recueillies sur les caractĂ©ristiques dĂ©mographiques,les comorbiditĂ©s, les complications, la natrĂ©mie, l'hĂ©moglobine, le dĂ©bit urinaire maximal, le rĂ©sidu post-mictionnel, l'IPSS et les complications.RĂ©sultats: L'Ăąge moyen Ă©tait de 78 ans, le volume prostatique moyen Ă©tait de 44g et le PSA Ă©tait de 3.4ng/ml. Parmi les 10 patients (21.2%)Ă©taient sous AVK, 27 (57.4%) Ă©taient sous aspirine, 2 (4.2%) Ă©taient sous clopidogrel, un sous fondaparinux et 6 (12.7%) Ă©taient sous 2 anticoagulants ou plus. Le score ASA moyen Ă©tait de 3. La durĂ©e moyenne de fonctionnement de l'appareil Ă©tait de 38 minutes, l'Ă©nergie moyenneutilisĂ©e Ă©tait de 200kJ. La durĂ©e moyenne d'hospitalisation Ă©tait de 2 jours. Les complications survenant dans les 30 jours comprenaient uneinfection urinaire chez 5 patients (10.6%), une dysurie chez 4 patients et une hĂ©morragie retardĂ©e chez 4 autres (8.5%). Un seul de ces patients anĂ©cessitĂ© une transfusion sanguine et aucun patient n'a nĂ©cessitĂ© une rĂ©intervention. En 3 mois de suivi un seul patient a nĂ©cessitĂ© une incision du col vĂ©sical pour sclĂ©rose du col. Aucune incontinence ou stĂ©nose urĂ©trale n'a Ă©tĂ© rapportĂ©e. Des amĂ©liorations significatives ont Ă©tĂ© notĂ©es dans l'IPSS, le dĂ©bit urinaire maximal et le rĂ©sidu post-mictionnel. Conclusion: La PVP est caractĂ©risĂ© par d'excellentes propriĂ©tĂ©s hĂ©mostatiques et taux trĂšs faible de complications peropĂ©ratoires mĂȘme chez les patients sous 2 ou plusieurs agents anticoagulants. Sur la base de nos rĂ©sultats pĂ©ri-opĂ©ratoires, nous recommandons la PVP comme traitement chirurgical de premiĂšre intention chez les patients Ă haut risque de hĂ©morragique souffrant de symptĂŽmes d'hypertrophie bĂ©nigne de la prostate
La recherche juridique sur les prélÚvements biologiques réalisés dans le cadre des autopsies et objets de scellés judiciaires. Nécessité d'une adaptation législative
Currently, it is legally impossible to conduct scientific research on tissue and organ samples taken from forensic autopsies. In fact, the law schedules the destruction of such samples at the end of the judicial investigation, and the common law rules governing cadaver research cannot be applied to the forensic context. However, nothing seems in itself to stand in the way of such research since, despite their specific nature, these samples from forensic autopsies could be subject, following legislative amendments, to common law relating to medical research on samples taken from deceased persons. But an essential legislative amendment will have the goal firstly to allow the Biomedicine Agency to become authorized to issue a research permit and secondly, to change the research conditions in terms of the non-opposition of the deceased to the said research. Such an amendment would be a true breakthrough because it would allow teams to continue to move forward calmly in research, and allow this research to be placed within a legal framework, which would promote international exchanges
Changes in aortic blood flow induced by passive leg raising predict fluid responsiveness in critically ill patients
INTRODUCTION: Esophageal Doppler provides a continuous and non-invasive estimate of descending aortic blood flow (ABF) and corrected left ventricular ejection time (LVETc). Considering passive leg raising (PLR) as a reversible volume expansion (VE), we compared the relative abilities of PLR-induced ABF variations, LVETc and respiratory pulsed pressure variations (ÎPP) to predict fluid responsiveness. METHODS: We studied 22 critically ill patients in acute circulatory failure in the supine position, during PLR, back to the supine position and after two consecutive VEs of 250 ml of saline. Responders were defined by an increase in ABF induced by 500 ml VE of more than 15%. RESULTS: Ten patients were responders and 12 were non-responders. In responders, the increase in ABF induced by PLR was similar to that induced by a 250 ml VE (16% versus 20%; p = 0.15). A PLR-induced increase in ABF of more than 8% predicted fluid responsiveness with a sensitivity of 90% and a specificity of 83%. Corresponding positive and negative predictive values (PPV and NPV, respectively) were 82% and 91%, respectively. A ÎPP threshold value of 12% predicted fluid responsiveness with a sensitivity of 70% and a specificity of 92%. Corresponding PPV and NPV were 87% and 78%, respectively. A LVETc of 245 ms or less predicted fluid responsiveness with a sensitivity of 70%, and a specificity of 67%. Corresponding PPV and NPV were 60% and 66%, respectively. CONCLUSION: The PLR-induced increase in ABF and a ÎPP of more than 12% offer similar predictive values in predicting fluid responsiveness. An isolated basal LVETc value is not a reliable criterion for predicting response to fluid loading
Integrating virtual patients into undergraduate health professions curricula: a framework synthesis of stakeholders' opinions based on a systematic literature review
Background
Virtual patients (VPs) are widely used in health professions education. When they are well integrated into curricula, they are considered to be more effective than loosely coupled add-ons. However, it is unclear what constitutes their successful integration. The aim of this study was to identify and synthesise the themes found in the literature that stakeholders perceive as important for successful implementation of VPs in curricula.
Methods
We searched five databases from 2000 to September 25, 2023. We included qualitative, quantitative, mixed-methods and descriptive case studies that defined, identified, explored, or evaluated a set of factors that, in the perception of students, teachers, course directors and researchers, were crucial for VP implementation. We excluded effectiveness studies that did not consider implementation characteristics, and studies that focused on VP design factors. We included English-language full-text reports and excluded conference abstracts, short opinion papers and editorials. Synthesis of results was performed using the framework synthesis method with Kernâs six-step model as the initial framework. We appraised the quality of the studies using the QuADS tool.
Results
Our search yielded a total of 4808 items, from which 21 studies met the inclusion criteria. We identified 14 themes that formed an integration framework. The themes were: goal in the curriculum; phase of the curriculum when to implement VPs; effective use of resources; VP alignment with curricular learning objectives; prioritisation of use; relation to other learning modalities; learning activities around VPs; time allocation; group setting; presence mode; VPs orientation for students and faculty; technical infrastructure; quality assurance, maintenance, and sustainability; assessment of VP learning outcomes and learning analytics. We investigated the occurrence of themes across studies to demonstrate the relevance of the framework. The quality of the studies did not influence the coverage of the themes.
Conclusions
The resulting framework can be used to structure plans and discussions around implementation of VPs in curricula. It has already been used to organise the curriculum implementation guidelines of a European project. We expect it will direct further research to deepen our knowledge on individual integration themes
Low Temperature Plasma Synthesis of Nanocrystals and their Application to the Growth of Crystalline Silicon and Germanium Thin Films
International audienceWe summarize our research studies on the synthesis of silicon and germanium nanocrystals and their application to the growth of a variety of thin films, spanning the range from fully disordered amorphous up to fully ordered crystalline. All these films are deposited in a standard radio-frequency glow discharge system at low temperature (~200 °C). We show how the plasma synthesis of silicon nanocrystals, initially a side effect of powder formation, has become over the years an exciting field of research which has opened the way to new opportunities in the field of materials deposition and their application to optoelectronic devices. Our results suggest that epitaxy requires the melting/amorphization of the nanocrystals upon impact on the substrate, the subsequent epitaxial growth being favored on (100) c-Si substrates. As a consequence, the control of the impact energy is a critical aspect of the growth which will require new strategies such as the use of tailored voltage waveforms
Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTandem2
Objective: Evaluate the effect of sotagliflozin, a dual inhibitor of sodium glucose cotransporter (SGLT) 1 and 2, on arterial stiffness in patients with type 1 diabetes (T1D) treated with sotagliflozin as adjunct to optimized insulin therapy. Methods: In this post hoc analysis, indirect markers of arterial stiffness, including pulse pressure, mean arterial pressure (MAP), and double product, were calculated using observed systolic blood pressure (SBP), diastolic blood pressure (DBP), or pulse rate at 24 weeks using data from a pooled patient population from the inTandem1 and inTandem2 randomized controlled trials (n = 1575). Results: Baseline characteristics were similar among groups. Relative to placebo at Week 24, sotagliflozin 200 mg and 400 mg reduced SBP by 2.03 mm Hg (95% CI â3.30 to â0.75; p = 0.0019) and 2.85 mm Hg (â4.12 to â1.57; p < 0.0001), respectively. DBP decreased by 1.1 and 0.9 mm Hg, MAP by 1.4 and 1.6 mm Hg, and double product by 202.5 and 221.1 bpm Ă mm Hg, respectively (p < 0.05 for all). No increases in heart rate were observed. Conclusion: In adults with T1D, adding sotagliflozin to insulin significantly reduced blood pressure and other markers of arterial stiffness and vascular resistance
- âŠ